1,206
Participants
Start Date
November 28, 2017
Primary Completion Date
August 31, 2020
Study Completion Date
August 30, 2021
intravenous Placebo
Patients receive intravenous Placebo (saline) injection
Metoprolol Injectable Product
Patients receive intravenous Metoprolol injection
Romote Ischemic Conditioning (RIC)
Patients receive RIC treatment
Metoprolol & RIC
Patients receive Metoprolol \& RIC treatment
Peking Univerisity People'Hospital, Beijing
The Second Hospital of Jilin University, Changchun
Daqing Oilfield General Hospital, Daqing
Zhongda Hospital Southeast University, Nanjing
The Second Affiliated Hospital of Nanchang University, Nanchang
Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Guangdong general hospital, Guangzhou
Second hospital of hebei medical university, Shijiazhuang
The first affiliated hospital of Zhengzhou medical university, Zhengzhou
the second affiliated hospital of Dalian medical university, Dalian
Shenyang military district general hospital of the people's liberation army, Shenyang
The first affiliated hospital of military medical university, Xi’an
Third Military Medical University, Chongqing
The General Hospital of Tianjin Medical University, Tianjin
Tianjin Chest Hospital, Tianjin
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Beijing Chao Yang Hospital
OTHER
Harbin Medical University
OTHER